Ipilimumab 50mg/10ml solution for infusion vials
NHS hospitals in England used £57,948,900 of indicative cost of Ipilimumab 50mg/10ml solution for infusion vials in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 14.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ipilimumab 50mg/10ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ipilimumab 50mg/10ml solution for infusion vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Royal Marsden Nhs Foundation Trust | £2,752,500 |
| United Lincolnshire Hospitals Nhs Trust | £1,856,250 |
| Manchester University Nhs Ft | £1,825,125 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,742,625 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,728,750 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,687,500 |
| University Hospital Southampton Nhs Ft | £1,631,250 |
| Hull And East Yorkshire Hpls Nhs Trust | £1,612,500 |
| Nottingham University Hospitals Trust | £1,492,500 |
| Sheffield Teaching Hospitals Nhs Trust | £1,462,500 |
The primary-care picture
Ipilimumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ipilimumab medicine page.